Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system ...

Mayor Eric Adams’ administration plans to study the city’s commercial real estate industry to determine whether minority- and ...

Affordable housing developer Eli Bronfman, whose family controlled the Seagram Co. for decades, has listed his SoHo penthouse ...

The strike threat led city elected officials, including members of the City Council and Mayor Eric Adams, to intervene, and ...

Although there is not a current active strike notice, the public hospital system is making tentative plans to cancel elective ...

Thanks to a series of last-minute carve-outs, New York City’s controversial new employment rules for hotels will have a far ...

The latest phase of the Second Avenue project is expected to cost a total of $7.7 billion, including a $3.4 billion grant ...

Pershing Square Capital Management has proposed a deal to merge a newly formed subsidiary with Howard Hughes Holdings, the ...

The unit’s price per square foot, $3,700, puts the deal in the upper tier of new condo sales. In fact, in the fourth quarter ...

The announcement, made on the same day that the $9 congestion pricing toll took effect, was a smart move by Hochul, who has ...

In this Q&A, Joe Dorazio, Small Group Head of Sales – at Aetna ®, a CVS Health ® Company, addresses common questions about ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.